The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Share News (PRTC)

Share Price Information for PureTech (PRTC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 225.50
Bid: 226.00
Ask: 227.00
Change: -1.00 (-0.44%)
Spread: 1.00 (0.442%)
Open: 226.50
High: 229.00
Low: 224.50
Prev. Close: 226.50
PRTC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: Insig AI executive chair and Palace Capital CFO out

Fri, 13th Aug 2021 14:45

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Friday and not separately reported by Alliance News:

----------

Insig AI PLC - venture capital firm formerly known as Catena Group PLC - Matthew Farnum-Schneider resigns as executive chair, leaving after a short handover period, having served for two years. Richard Bernstein, "a long-term supporter and shareholder", is named interim non-executive chair until a permanent independent non-executive chair can be found. Bernstein, a 12.6% shareholder in Insig AI, was investment manager of AIM-listed Crystal Amber Fund Ltd.

----------

Palace Capital PLC - investor in regional UK commercial real estate - Stephen Silvester steps down as chief financial officer, leaving the board on October 29 after six years with Palace Capital. Head of Finance & Operations Matthew Simpson is promoted to finance director designate.

----------

US Solar Fund PLC - owns and operates solar power assets in North America - Notes that New Energy Solar Manager, the fund's manager, has promoted Liam Thomas to chief executive officer from chief investment officer. Thomas joined NESM in 2016 and has 17 years experience in the renewable energy, infrastructure, and agribusiness sectors, US Solar Fund says. Thomas replaces John Martin, who is leaving on September 30 to join renewable energy developer Windlab Pty Ltd.

----------

City Of London Investment Trust PLC - Hires Ominder Dhillon as a non-executive director, starting September 1. Dhillon was global head of Institutional Distribution at asset manager M&G PLC until the start of 2020. Prior M&G, he was head of Distribution at Impax Asset Management Group PLC.

----------

Keywords Studios PLC - Dublin-based technical services for video game developers - Hires Marion Sears and Neil Thompson as independent non-executive directors, starting immediately. Sears was a City analyst and investment banker. She currently is a non-executive director of retailer Dunelm Group PLC and senior independent director of Fidelity European Trust PLC and of Aberdeen New Dawn Investment Trust PLC. Thompson held senior positions at software firm Microsoft Corp and was part of the management team that launched Xbox into Europe, Keywords notes.

----------

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics - Hires Julie Krop as chief medical officer, joining from Nasdaq-listed Freeline Therapeutics Holdings PLC, where she held the same position.

----------

Prospex Energy PLC - investor in onshore and shallow offshore European gas and power projects - Receives letter from group of shareholders requisitioning a general meeting to remove existing and proposed directors and appoint new ones. Prospex says the documentation received doesn't form a valid request. Therefore, it won't call the meeting. However, the board has spoken to the shareholders and invited them to submit a valid request. Shareholders last month rejected the re-appointment of James Smith as a director, and the board currently has only three members.

----------

Trinity Exploration & Production PLC - oil assets in Trinidad and Tobago - Confirms Nicholas Clayton as permanent non-executive chair. Clayton had taken on the role on an interim basis following the death earlier this month of Bruce Dingwall, who had been executive chair. Managing Director Jeremy Bridglalsingh is promoted to CEO.

----------

Block Energy PLC - oil and gas development and production company focused on Georgia - Hires Jeremy Asher as non-executive director, effective immediately. Asher is chair & CEO of AIM-listed Tower Resources PLC. Block Energy shareholders at a general meeting on Wednesday had rejected proposals by Forest Nominees Ltd, acting on behalf of GP Jersey Ltd, to remove Chair Philip Dimmock and replace him with Charles Valceschini. Over 60% of votes were against both resolutions.

----------

Abcam PLC - Cambridge, England-based life science research tools - Hires Sally Crawford as non-executive director, starting immediately. Crawford was chief operating officer of US managed care firm Healthsource Inc and now is a health care consultant, based in New Hampshire.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 Aug 2022 17:06

LONDON MARKET CLOSE: Strong start to week as US inflation data looms

(Alliance News) - Stocks in London sprang into the new week after Friday's US jobs data lessened recession fears.

Read more
8 Aug 2022 16:21

IN BRIEF: PureTech shares jump on Karuna Therapeutics trial results

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Says founded entity Karuna Therapeutics reports positive phase III trial results from Emergent-2 trial for KarXT in schizophrenia. KarXT, or xanomeline-trospium, met its primary endpoint in the trial, showing a significant 9.6 point reduction in Positive and Negative Syndrome Scale total score compared to a placebo. The PANSS scale measures the symptom severity of patients with schizophrenia. The trial also met key secondary endpoints, the firm says. Karuna plans to submit a new drug application with the US Food & Drug Administration in mid-2023.

Read more
1 Aug 2022 21:21

IN BRIEF: PureTech Health's Aliki starts phase three study for SDT-001

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Notes that founded entity Akili Interactive Labs Inc has start a pivotal phase three randomised, controlled study of SDT-001, a candidate designed to improve the measures of attention in children diagnosed with ADHD.

Read more
11 Jul 2022 19:15

TRADING UPDATES: BlueRock hit by extreme weather; Harbour drills well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
30 Jun 2022 21:50

IN BRIEF: PureTech Health begins pulmonary fibrosis study

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Begins late-stage clinical study of its wholly-owned candidate LYT-100, or deupirfenidone, in idiopathic pulmonary fibrosis. Will evaluate efficacy of two doses, as well as relative tolerability and efficacy with pirfenidone. IPF is a chronic condition causing progressive scarring of the lungs, which currently has a poor prognosis. Also advances LYT-200 programme through clinical development, and plans to begin leukemia study by the end of 2022.

Read more
28 Jun 2022 14:45

IN BRIEF: PureTech Health's founded firm Vedanta launches new facility

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics firm - Announces that its founded firm Entity Vedanta Biosciences Inc launches a new manufacturing facility. The facility will "provide clinical and commercial supply of oral therapies" for people infected with a diarrhoea-causing bacteria, firm says.

Read more
21 Jun 2022 14:24

IN BRIEF: PureTech Health's Gelesis wins USD15 million Plenity order

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics - Investee Gelesis Holdings Inc receives another USD15 million pre-order for its weight management aid product Plenity from its distribution partner, New-York based telehealth firm Ro. It brings the total orders from Ro to USD55 million, out of which USD45 million was ordered in the last 12 months, PureTech Health adds.

Read more
14 Jun 2022 16:54

IN BRIEF: PureTech achieves availability milestone for LYT-300 study

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics - Announces results from phase two study of LYT-100-COV on patients with post acute or long Covid with respiratory complications.

Read more
14 Jun 2022 07:33

PureTech reports 'Glyph' milestone, disappointing long Covid results

(Sharecast News) - PureTech Health said on Tuesday that it had met a milestone in proving its 'Glyph' therapeutic platform, while separately announcing disappointing results from a study into long Covid.

Read more
1 Jun 2022 18:21

TOP NEWS: Centrica warms up for FTSE 100 as Royal Mail sent packing

(Alliance News) - FTSE Russell confirmed on Wednesday that the following changes will take effect to its UK indices from the market open on Monday, June 20 after completing its quarterly review.

Read more
25 May 2022 10:18

Centrica and Johnson Matthey indicated to join FTSE 100, Asos in 250

(Alliance News) - British Gas-owner Centrica PLC and chemical firm Johnson Matthey PLC are set to return to the FTSE 100 index next month, replacing television broadcaster ITV PLC and postal operator Royal Mail PLC, according to indicative changes released by FTSE Russell on Tuesday.

Read more
5 May 2022 12:11

LONDON MARKET MIDDAY: Pound slips as BoE opts for quarter-point hike

(Alliance News) - Stock prices in London were higher, while the pound was flat, on Thursday, after the Bank of England as expected raised UK interest rates by a quarter percentage point.

Read more
5 May 2022 11:18

IN BRIEF: PureTech shares rise as unveils USD50 million share buyback

PureTech Health PLC - Boston, Massachusetts-based clinical-stage biotherapeutics - Approves share buyback of up to USD50 million. Programme follows "follows consultation with shareholders and is consistent with PureTech's capital allocation strategy and stated approach to drive additional value for its shareholders," company says. PureTech says it had USD413.2 million of net cash and cash equivalents at March 31. Given size of balance sheet, PureTech is confident it can return capital to shareholders and also maintain "sufficient cash on hand to deliver" on strategic priorities.

Read more
5 May 2022 10:09

PureTech to buy back up to $50m of shares

(Sharecast News) - PureTech Health has announced a $50m share buyback programme, sending shares in the FTSE 250 biotech sharply higher.

Read more
4 May 2022 13:35

PureTech entity Gelesis reports positive data for weight loss drug

(Alliance News) - Boston-based biotechnology company PureTech Health PLC's founded entity Gelesis Holdings Inc said on Wednesday that its weight loss drug showed positive responses in adults in clinical trials.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.